Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Georgia Bard's Corner -- Ignore unavailable to you. Want to Upgrade?

To: jeffrey rainey who wrote (980)	4/30/1998 10:39:00 AM
From: Ga Bard	Read Replies (1) \| Respond to of 9440

MEGH ... Well I think it is going to be very interesting ... The charters are imprtant also and checking up on them to. This is an example of not selling for a mega loss in these shells actually they can teach you more about this industry than anything else because you have to dig deep/ I Owe Donald Steinman I grant you GB CNHH 1.125 0 1.125 1.313 0 +0.0% MIDLP 12.000 1000 12.000 15.000 1000 -22.6% MIDLW 0.170 0 0.140 0.170 0 +0.0% MIDL 0.656 100 0.563 0.656 1100 +0.0% AVBC 0.328 2000 0.280 0.300 81400 +17.1% SURG 2.750 100 2.531 2.781 5900 +3.5% MEGH 0.230 35000 0.190 0.240 241700 +9.5% MXNT 2.688 7500 2.687 2.812 21300 -2.3% BLHG 0.900 1000 0.593 0.968 8800 +20.0% IKAR 0.969 500 0.968 1.062 500 -3.1% CSCA 0.200 0 0.160 0.210 0 +0.0% GLCP 0.188 25000 0.180 0.200 3213800 +10.6% ABMI 0.690 5000 0.680 0.700 106500 +0.0% TSIS 0.490 10000 0.480 0.500 72000 -2.0% ALYA 1.390 4000 1.390 1.430 340800 -7.9% CSHK 0.400 1000 0.400 0.410 39500 -2.4% CFCC 0.260 3700 0.260 0.280 3700 +0.0% AUTO 3/8 1500 3/8 13/32 575 +20.0% NRAG 0.270 4000 0.230 0.270 7000 +8.0% ITKG 1.000 2000 1.000 1.062 45800 +0.0% MDCE 0.180 5000 0.175 0.185 538200 +28.6% PHXU 0.750 5000 0.750 0.812 24000 -4.0%

To: jeffrey rainey who wrote (980)	4/30/1998 10:39:00 AM
From: PK	Read Replies (3) \| Respond to of 9440

AMDD ...NEWS JUST OUT Thursday April 30, 10:00 am Eastern Time Company Press Release SOURCE: AMDL, Inc. AMDL Files for FDA Clearance PyloriProbe(TM) Diagnostic Test TUSTIN, Calif., April 30 /PRNewswire/ -- AMDL, Inc., (OTC Bulletin Board: AMDD - news) an inventor and marketer of state-of-the art diagnostic kits, today announced it has filed a 510(k) submission with the U.S. Food and Drug Administration requesting clearance to market in the United States its PyloriProbe(TM) diagnostic test for the detection of the bacterium known to cause gastric and duodenal ulcers and, if untreated, stomach cancer. Helicobacter pylori infection is believed to be the most prevalent disease on earth, impacting almost one of every three people. Available antibiotic treatment can usually rid the stomach of the bacterium. The AMDL submission follows clinical trials involving 395 patients at medical centers in California, Ohio, Tennessee and Oregon. AMDL's non-invasive diagnostic test, a direct enzyme immunoassay, determines whether there are antibodies to the bacterium in the patient's blood. AMDL, headquartered in Tustin, CA, (OTC Bulletin Board: AMDD - news), is also engaged in applying innovative technology to develop novel and improved diagnostic tests for the early detection of cancer. AMDL also markets other high-quality diagnostic tests worldwide. Except for the historical information contained herein, the matters discussed are forward-looking statements which involve risks and uncertainties, including, but not limited to, economic, competitive, governmental, and technological factors affecting the revenues, operations, markets, products, prices and other factors discussed in the Company's various filings with the Securities and Exchange Commission. SOURCE: AMDL, Inc.